Furthermore, EMT has been reported to be related to reduced sensitivity and acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKI) in lung cancer cells (17–19). The gene discussed is EGFR; the disease is lung carcinoma.